Corvus Pharmaceuticals (CRVS) EPS (Basic) (2015 - 2026)
Corvus Pharmaceuticals' (CRVS) quarterly EPS (Basic) came in at -$0.15 in Q1 2026, down 166.7% year-on-year from $0.22 in Q1 2025, and down 22.55% quarter-over-quarter from -$0.12 in Q3 2025.
Corvus Pharmaceuticals (CRVS) EPS (Basic) (2015 - 2026) Analysis & Trends
Corvus Pharmaceuticals' EPS (Basic) history runs 12 years deep, the most recent figure standing at -$0.15 for Q1 2026.
- On a quarterly basis, EPS (Basic) fell 166.7% year-over-year to -$0.15 in Q1 2026; TTM through Mar 2026 was -$0.34, a 10.97% increase from a year earlier, with the FY2025 full-year figure at -$1.29, up 12.9% from the prior year.
- EPS (Basic) declined to -$0.15 in Q1 2026 per CRVS's latest filing, from -$0.12 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.22 in Q1 2025 and bottomed at -$0.59 in Q3 2024.
- The 5-year median for EPS (Basic) is -$0.12 (2024), against an average of -$0.14.
- Across the five-year window, EPS (Basic) slumped 465.26% in 2024 and soared 280.16% in 2025, its largest moves.
- Year by year, EPS (Basic) stood at -$0.12 in 2022, then increased by 3.84% to -$0.12 in 2023, then slumped by 396.61% to -$0.59 in 2024, then soared by 79.97% to -$0.12 in 2025, then fell by 22.55% to -$0.15 in 2026.
- Per Business Quant, the three latest CRVS EPS (Basic) figures stand at -$0.15 (Q1 2026), -$0.12 (Q3 2025), and -$0.1 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Corvus Pharmaceuticals | 1.23 Bn | 1.23 Bn | - | -0.15 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.15 |
| Sep 30, 2025 | -0.12 |
| Jun 30, 2025 | -0.10 |
| Mar 31, 2025 | 0.22 |
| Sep 30, 2024 | -0.59 |
| Jun 30, 2024 | -0.06 |
| Mar 31, 2024 | -0.12 |
| Dec 31, 2023 | -0.12 |
| Sep 30, 2023 | -0.10 |
| Jun 30, 2023 | -0.11 |
| Mar 31, 2023 | -0.13 |
| Dec 31, 2022 | -0.12 |
| Sep 30, 2022 | -0.27 |
| Jun 30, 2022 | -0.16 |
| Mar 31, 2022 | -0.17 |
| Dec 31, 2021 | -0.17 |
| Sep 30, 2021 | -0.22 |
| Jun 30, 2021 | -0.28 |
| Mar 31, 2021 | -0.34 |
| Dec 31, 2020 | -0.35 |